Compare OCS & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCS | NB |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 737.6M |
| IPO Year | N/A | N/A |
| Metric | OCS | NB |
|---|---|---|
| Price | $20.64 | $5.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $39.80 | $6.17 |
| AVG Volume (30 Days) | 97.6K | ★ 4.2M |
| Earning Date | 11-10-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $991,999.00 | N/A |
| Revenue This Year | $35.00 | N/A |
| Revenue Next Year | $874.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.00 | $1.36 |
| 52 Week High | $23.08 | $12.58 |
| Indicator | OCS | NB |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 43.37 |
| Support Level | $18.64 | $6.43 |
| Resistance Level | $21.86 | $7.09 |
| Average True Range (ATR) | 0.63 | 0.51 |
| MACD | 0.16 | 0.05 |
| Stochastic Oscillator | 62.73 | 20.98 |
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.